A Phase II NCCTG Study of Irinotecan and Docetaxel in Previously Treated Patients with Non-Small Cell Lung Cancer

By Molina Julian   Nikcevich Daniel   Hillman Shauna   Geyer Susan   Drevyanko Timothy   Jett James   Verdirame Joseph   Tazelaar Henry   Rowland Kendrith   Wos Edward   Kutteh Leila   Nair Suresh   Fitch Tom   Flynn Patrick   Stella Philip   Adjei Alex  

Cancer Investigation, Vol. 24, Iss. 4, 2006-07 ,pp. : 382-389

Informa Healthcare

Access to resources Recommend Favorite

Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: A Korean Cancer Study Group Trial

By Kim Tae Won   Kang Won Ki   Chang Heung Moon   Park Joon Oh   Ryoo Baek Yeol   Ahn Jin Seok   Zang Dae Young   Lee Kyung Hee   Kang Yoon Koo   Kim Sung Rok   Kim Hoon-Kyo  

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 230-235

Informa Healthcare

Access to resources Recommend Favorite

A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer

By Jeung Hei-Cheul   Rha Sun   Noh Sung   Roh Jae   Chung Hyun  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 3, 2007-03 ,pp. : 313-320

Springer Publishing Company

Access to resources Recommend Favorite

A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour study

By Hargrave Darren  

Journal of Neuro-Oncology, Vol. 113, Iss. 1, 2013-05 ,pp. : 127-134

Springer Publishing Company

Access to resources Recommend Favorite

Irinotecan plus cisplatin combination against metastatic gastric cancer: Phase II study

By Altinbas Mustafa   Er Ozlem   Ozkan Metin   Solak Yusuf   Coskun H.   Kucuk Can   Gursoy Sebnem  

Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. : 153-160

Humana Press, Inc

Access to resources Recommend Favorite